Targeted Integration of EpCAM-Specific CAR in Human Induced Pluripotent Stem Cells and Their Differentiation into NK Cells

Scientists genetically modified human iPSCs with a zinc finger nuclease technology to introduce a cDNA encoding an anti-EpCAM chimeric antigen receptor into the adeno-associated virus integration site 1, a “safe harbour” for transgene insertion into human genome.